BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Sep 8, 2022
Discovery & Translation

An inroad to bunyaviruses; plus a gene therapy for tyrosinemia and more

BioCentury’s roundup of translational news
BioCentury | Oct 19, 2021
Discovery & Translation

CRISPR innovation hits the gas

A burst of research is radically expanding tools to optimize CRISPR therapies and access new targets
BioCentury | Oct 16, 2021
Discovery & Translation

Prime editing pileup; plus Travera, Emulate, bitBiome and more

BioCentury’s roundup of translational news
BioCentury | Oct 11, 2018
Distillery Therapeutics

Endocrine/metabolic

BioCentury | Aug 18, 2016
Distillery Therapeutics

Therapeutics: Fumarylacetoacetate hydrolase (FAH)

BioCentury | Jul 21, 2016
Translation in Brief

Survival of the modified

How gene therapies can give themselves a leg up in the liver
BioCentury | Oct 2, 2014
Tools & Techniques

A CRISPR possibility for DMD

BioCentury | Apr 24, 2014
Cover Story

CRISPR in the liver

BioCentury | Apr 17, 2014
Distillery Techniques

Technology: Drug platforms

Items per page:
1 - 10 of 13